Reducing Cardiovascular Risk in the Patient with Elevated Triglycerides

Speaker Name/Credentials

Alan S. Brown, M.D.
Director, Division of Cardiology and the Lipid Clinic Advocate Lutheran General Hospital
Clinical Associate Professor, Loyola University Medical Center

Estimated Time of Talk

45 minutes


This webinar will cover clinical implications and therapeutic approaches to patients with hypertriglyceridemia.

Learning Objectives

  1. Understand the effect of hypertriglyceridemia on CHD risk.
  2. Review treatment strategies to reduce risk of pancreatitis and CHD events.
  3. Review appropriate therapies for patients with elevated triglycerides.

Conflicts of Interest

Speaker- Amgen, Regeneron, Sanofi, Advisory Board- Amarin, Kastle, Kowa, Pfizer, Sanofi

Share this: